Ocular drug permeation following experimental excimer laser treatment on the isolated pig eye

Excimer laser photorefractive keratectomy (PRK) is a well-established procedure which is frequently applied to correct myopia. Since structural alterations of the corneal epithelium occur after the treatment, a different drug permeation can be assumed. To investigate the effects of PRK on drug perme...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of ocular pharmacology and therapeutics 2002-04, Vol.18 (2), p.177-183
Hauptverfasser: SCHOLZ, Martina, SCHRÜNDER, Stephan, GÄRTNER, Sven, KEIPERT, Sigrid, HARTMANN, Christian, PLEYER, Uwe
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 183
container_issue 2
container_start_page 177
container_title Journal of ocular pharmacology and therapeutics
container_volume 18
creator SCHOLZ, Martina
SCHRÜNDER, Stephan
GÄRTNER, Sven
KEIPERT, Sigrid
HARTMANN, Christian
PLEYER, Uwe
description Excimer laser photorefractive keratectomy (PRK) is a well-established procedure which is frequently applied to correct myopia. Since structural alterations of the corneal epithelium occur after the treatment, a different drug permeation can be assumed. To investigate the effects of PRK on drug permeation, excimer laser ablations with varying depths were performed on isolated pig eyes. The permeation of lipophilic (diclofenac-sodium; D-Na) and hydrophilic (pilocarpine-hydrochloride; P-HCl model drugs were studied in vitro. Under these experimental conditions, P-HCl demonstrated a significant (p < 0.05) enhancement of permeation in relation to the ablation depth. In contrast, corneal epithelial thickness scarcely influenced the permeation rate of D-Na. Not until removing the entire epithelium did a significantly increased permeability occur, when compared to untreated cornea. These results suggest that PRK may significantly reduce the corneal barrier function and alter pharmacokinetics of topical medication.
doi_str_mv 10.1089/108076802317373923
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71670804</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71670804</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-c012ff3e5df82fa0331841b2abc0e8b0f84cdb82002d7657d1257baadeb66203</originalsourceid><addsrcrecordid>eNplkMtOwzAQRS0EoqXwAyyQN7ALjO0kTpcI8ZIqddMtihx7XIKcB3Yi6N_jqpG6YDMPz7kjzyXkmsE9g2L5EAPIvAAumBRSLLk4IXOWZTKRUvDTWEcgiYSYkYsQvgCYgJydkxnjADyXMCcfaz065anx45b26BtUQ9211HbOdT91u6X4G5_rBttBudjoWHrqVIhx8JHeT2hUDJ9I69A5NaChfR2FO7wkZ1a5gFdTXpDNy_Pm6S1ZrV_fnx5XiU55OiQaGLdWYGZswa0CIViRsoqrSgMWFdgi1aYq9p82Ms-kYTyTlVIGqzznIBbk7rC29933iGEomzpodE612I2hlCzeWkAaQX4Ate9C8GjLPp6m_K5kUO49Lf97GkU30_axatAcJZOJEbidABW0ctarVtfhyImcZylj4g8K3n-C</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71670804</pqid></control><display><type>article</type><title>Ocular drug permeation following experimental excimer laser treatment on the isolated pig eye</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>SCHOLZ, Martina ; SCHRÜNDER, Stephan ; GÄRTNER, Sven ; KEIPERT, Sigrid ; HARTMANN, Christian ; PLEYER, Uwe</creator><creatorcontrib>SCHOLZ, Martina ; SCHRÜNDER, Stephan ; GÄRTNER, Sven ; KEIPERT, Sigrid ; HARTMANN, Christian ; PLEYER, Uwe</creatorcontrib><description>Excimer laser photorefractive keratectomy (PRK) is a well-established procedure which is frequently applied to correct myopia. Since structural alterations of the corneal epithelium occur after the treatment, a different drug permeation can be assumed. To investigate the effects of PRK on drug permeation, excimer laser ablations with varying depths were performed on isolated pig eyes. The permeation of lipophilic (diclofenac-sodium; D-Na) and hydrophilic (pilocarpine-hydrochloride; P-HCl model drugs were studied in vitro. Under these experimental conditions, P-HCl demonstrated a significant (p &lt; 0.05) enhancement of permeation in relation to the ablation depth. In contrast, corneal epithelial thickness scarcely influenced the permeation rate of D-Na. Not until removing the entire epithelium did a significantly increased permeability occur, when compared to untreated cornea. These results suggest that PRK may significantly reduce the corneal barrier function and alter pharmacokinetics of topical medication.</description><identifier>ISSN: 1080-7683</identifier><identifier>EISSN: 1557-7732</identifier><identifier>DOI: 10.1089/108076802317373923</identifier><identifier>PMID: 12002670</identifier><language>eng</language><publisher>Larchmont, NY: Liebert</publisher><subject>Animals ; Biological and medical sciences ; Diclofenac - pharmacokinetics ; Eye ; Eye - metabolism ; In Vitro Techniques ; Laser Therapy ; Medical sciences ; Miscellaneous ; Ophthalmic Solutions - pharmacokinetics ; Ophthalmologic Surgical Procedures ; Ophthalmology ; Permeability ; Pharmacology. Drug treatments ; Pilocarpine - pharmacokinetics ; Swine</subject><ispartof>Journal of ocular pharmacology and therapeutics, 2002-04, Vol.18 (2), p.177-183</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-c012ff3e5df82fa0331841b2abc0e8b0f84cdb82002d7657d1257baadeb66203</citedby><cites>FETCH-LOGICAL-c424t-c012ff3e5df82fa0331841b2abc0e8b0f84cdb82002d7657d1257baadeb66203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3028,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13625411$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12002670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SCHOLZ, Martina</creatorcontrib><creatorcontrib>SCHRÜNDER, Stephan</creatorcontrib><creatorcontrib>GÄRTNER, Sven</creatorcontrib><creatorcontrib>KEIPERT, Sigrid</creatorcontrib><creatorcontrib>HARTMANN, Christian</creatorcontrib><creatorcontrib>PLEYER, Uwe</creatorcontrib><title>Ocular drug permeation following experimental excimer laser treatment on the isolated pig eye</title><title>Journal of ocular pharmacology and therapeutics</title><addtitle>J Ocul Pharmacol Ther</addtitle><description>Excimer laser photorefractive keratectomy (PRK) is a well-established procedure which is frequently applied to correct myopia. Since structural alterations of the corneal epithelium occur after the treatment, a different drug permeation can be assumed. To investigate the effects of PRK on drug permeation, excimer laser ablations with varying depths were performed on isolated pig eyes. The permeation of lipophilic (diclofenac-sodium; D-Na) and hydrophilic (pilocarpine-hydrochloride; P-HCl model drugs were studied in vitro. Under these experimental conditions, P-HCl demonstrated a significant (p &lt; 0.05) enhancement of permeation in relation to the ablation depth. In contrast, corneal epithelial thickness scarcely influenced the permeation rate of D-Na. Not until removing the entire epithelium did a significantly increased permeability occur, when compared to untreated cornea. These results suggest that PRK may significantly reduce the corneal barrier function and alter pharmacokinetics of topical medication.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Diclofenac - pharmacokinetics</subject><subject>Eye</subject><subject>Eye - metabolism</subject><subject>In Vitro Techniques</subject><subject>Laser Therapy</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Ophthalmic Solutions - pharmacokinetics</subject><subject>Ophthalmologic Surgical Procedures</subject><subject>Ophthalmology</subject><subject>Permeability</subject><subject>Pharmacology. Drug treatments</subject><subject>Pilocarpine - pharmacokinetics</subject><subject>Swine</subject><issn>1080-7683</issn><issn>1557-7732</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkMtOwzAQRS0EoqXwAyyQN7ALjO0kTpcI8ZIqddMtihx7XIKcB3Yi6N_jqpG6YDMPz7kjzyXkmsE9g2L5EAPIvAAumBRSLLk4IXOWZTKRUvDTWEcgiYSYkYsQvgCYgJydkxnjADyXMCcfaz065anx45b26BtUQ9211HbOdT91u6X4G5_rBttBudjoWHrqVIhx8JHeT2hUDJ9I69A5NaChfR2FO7wkZ1a5gFdTXpDNy_Pm6S1ZrV_fnx5XiU55OiQaGLdWYGZswa0CIViRsoqrSgMWFdgi1aYq9p82Ms-kYTyTlVIGqzznIBbk7rC29933iGEomzpodE612I2hlCzeWkAaQX4Ate9C8GjLPp6m_K5kUO49Lf97GkU30_axatAcJZOJEbidABW0ctarVtfhyImcZylj4g8K3n-C</recordid><startdate>20020401</startdate><enddate>20020401</enddate><creator>SCHOLZ, Martina</creator><creator>SCHRÜNDER, Stephan</creator><creator>GÄRTNER, Sven</creator><creator>KEIPERT, Sigrid</creator><creator>HARTMANN, Christian</creator><creator>PLEYER, Uwe</creator><general>Liebert</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020401</creationdate><title>Ocular drug permeation following experimental excimer laser treatment on the isolated pig eye</title><author>SCHOLZ, Martina ; SCHRÜNDER, Stephan ; GÄRTNER, Sven ; KEIPERT, Sigrid ; HARTMANN, Christian ; PLEYER, Uwe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-c012ff3e5df82fa0331841b2abc0e8b0f84cdb82002d7657d1257baadeb66203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Diclofenac - pharmacokinetics</topic><topic>Eye</topic><topic>Eye - metabolism</topic><topic>In Vitro Techniques</topic><topic>Laser Therapy</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Ophthalmic Solutions - pharmacokinetics</topic><topic>Ophthalmologic Surgical Procedures</topic><topic>Ophthalmology</topic><topic>Permeability</topic><topic>Pharmacology. Drug treatments</topic><topic>Pilocarpine - pharmacokinetics</topic><topic>Swine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SCHOLZ, Martina</creatorcontrib><creatorcontrib>SCHRÜNDER, Stephan</creatorcontrib><creatorcontrib>GÄRTNER, Sven</creatorcontrib><creatorcontrib>KEIPERT, Sigrid</creatorcontrib><creatorcontrib>HARTMANN, Christian</creatorcontrib><creatorcontrib>PLEYER, Uwe</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of ocular pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SCHOLZ, Martina</au><au>SCHRÜNDER, Stephan</au><au>GÄRTNER, Sven</au><au>KEIPERT, Sigrid</au><au>HARTMANN, Christian</au><au>PLEYER, Uwe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ocular drug permeation following experimental excimer laser treatment on the isolated pig eye</atitle><jtitle>Journal of ocular pharmacology and therapeutics</jtitle><addtitle>J Ocul Pharmacol Ther</addtitle><date>2002-04-01</date><risdate>2002</risdate><volume>18</volume><issue>2</issue><spage>177</spage><epage>183</epage><pages>177-183</pages><issn>1080-7683</issn><eissn>1557-7732</eissn><abstract>Excimer laser photorefractive keratectomy (PRK) is a well-established procedure which is frequently applied to correct myopia. Since structural alterations of the corneal epithelium occur after the treatment, a different drug permeation can be assumed. To investigate the effects of PRK on drug permeation, excimer laser ablations with varying depths were performed on isolated pig eyes. The permeation of lipophilic (diclofenac-sodium; D-Na) and hydrophilic (pilocarpine-hydrochloride; P-HCl model drugs were studied in vitro. Under these experimental conditions, P-HCl demonstrated a significant (p &lt; 0.05) enhancement of permeation in relation to the ablation depth. In contrast, corneal epithelial thickness scarcely influenced the permeation rate of D-Na. Not until removing the entire epithelium did a significantly increased permeability occur, when compared to untreated cornea. These results suggest that PRK may significantly reduce the corneal barrier function and alter pharmacokinetics of topical medication.</abstract><cop>Larchmont, NY</cop><pub>Liebert</pub><pmid>12002670</pmid><doi>10.1089/108076802317373923</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1080-7683
ispartof Journal of ocular pharmacology and therapeutics, 2002-04, Vol.18 (2), p.177-183
issn 1080-7683
1557-7732
language eng
recordid cdi_proquest_miscellaneous_71670804
source Mary Ann Liebert Online Subscription; MEDLINE
subjects Animals
Biological and medical sciences
Diclofenac - pharmacokinetics
Eye
Eye - metabolism
In Vitro Techniques
Laser Therapy
Medical sciences
Miscellaneous
Ophthalmic Solutions - pharmacokinetics
Ophthalmologic Surgical Procedures
Ophthalmology
Permeability
Pharmacology. Drug treatments
Pilocarpine - pharmacokinetics
Swine
title Ocular drug permeation following experimental excimer laser treatment on the isolated pig eye
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T04%3A45%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ocular%20drug%20permeation%20following%20experimental%20excimer%20laser%20treatment%20on%20the%20isolated%20pig%20eye&rft.jtitle=Journal%20of%20ocular%20pharmacology%20and%20therapeutics&rft.au=SCHOLZ,%20Martina&rft.date=2002-04-01&rft.volume=18&rft.issue=2&rft.spage=177&rft.epage=183&rft.pages=177-183&rft.issn=1080-7683&rft.eissn=1557-7732&rft_id=info:doi/10.1089/108076802317373923&rft_dat=%3Cproquest_cross%3E71670804%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71670804&rft_id=info:pmid/12002670&rfr_iscdi=true